Literature DB >> 26931154

Interleukin-1 in Stroke: From Bench to Bedside.

Oluwaseun A Sobowale1, Adrian R Parry-Jones1, Craig J Smith1, Pippa J Tyrrell1, Nancy J Rothwell1, Stuart M Allan2.   

Abstract

Entities:  

Keywords:  brain ischemia; cytokines; inflammation; interleukins; stroke

Mesh：

Substances：

Year:  2016        PMID： 26931154     DOI： 10.1161/STROKEAHA.115.010001

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  41 in total

Review 1.  Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

Authors:  Paul M Ridker
Journal:  Circ Res       Date:  2019-02       Impact factor: 17.367

Review 2.  Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Histol Histopathol       Date:  2020-02-06       Impact factor: 2.303

Review 3.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

4.  Developmental synaptic regulator, TWEAK/Fn14 signaling, is a determinant of synaptic function in models of stroke and neurodegeneration.

Authors:  Dávid Nagy; Katelin A Ennis; Ru Wei; Susan C Su; Christopher A Hinckley; Rong-Fang Gu; Benbo Gao; Ramiro H Massol; Chris Ehrenfels; Luke Jandreski; Ankur M Thomas; Ashley Nelson; Stefka Gyoneva; Mihály Hajós; Linda C Burkly
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

5.  PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.

Authors:  Nicholas E Powers; Benjamin Swartzwelter; Carlo Marchetti; Dennis M de Graaf; Alexandra Lerchner; Martin Schlapschy; Rajiv Datar; Uli Binder; Carl K Edwards; Arne Skerra; Charles A Dinarello
Journal:  J Biol Chem       Date:  2019-12-09       Impact factor: 5.157

Review 6.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 7.  Monoclonal antibody as an emerging therapy for acute ischemic stroke.

Authors:  Demi Woods; Qian Jiang; Xiang-Ping Chu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-08-25

Review 8.  Gasdermin Family: a Promising Therapeutic Target for Stroke.

Authors:  Sheng Chen; Shuhao Mei; Yujie Luo; Hemmings Wu; Jianmin Zhang; Junming Zhu
Journal:  Transl Stroke Res       Date:  2018-10-03       Impact factor: 6.829

Review 9.  Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.

Authors:  Shashank Shekhar; Mark W Cunningham; Mallikarjuna R Pabbidi; Shaoxun Wang; George W Booz; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-20       Impact factor: 4.432

10.  Dendrobium Alkaloids Promote Neural Function After Cerebral Ischemia-Reperfusion Injury Through Inhibiting Pyroptosis Induced Neuronal Death in both In Vivo and In Vitro Models.

Authors:  Daohang Liu; Zhi Dong; Fei Xiang; Hailin Liu; Yuchun Wang; Qian Wang; Jiangyan Rao
Journal:  Neurochem Res       Date:  2019-12-21       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.